Buy Clomid Online In Usa Levitra Be Ordered In Usa Name Buy Viagra Text Buy Viagra Buy Propecia From Canada Cialis And Liver Disease

 

 

Rhinology Online is a peer-reviewed, Open Access journal that accepts research articles, reviews, study protocols, case histories and special reports in rhinology.

Rhinology online open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience.

Rhinology online offers a fast publication schedule whilst maintaining rigorous peer review. Once your content is accepted it will be published online within days.

Online publication in Rhinology online gives you the opportunity to publish large datasets, large numbers of colour illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles).

Articles published in Rhinology online are included in article alerts and regular email updates. Some may be highlighted on Rhinology online website.

As an author of an article published in Clinical and Translational Allergy you retain the copyright of your article and you are free to reproduce and disseminate your work.

 

Rhinology is a worldwide non-profit making journal, which has an impact factor of 2.93. The journal was founded in 1963.

Rhinology publishes original papers on basic research as well as clinical studies in the major field of rhinology, including physiology, diagnostics, pathology, immunology, medical therapy and surgery of both the nose and paranasal sinuses. The publisher and editorial board believe the time is now right to launch a complementary open access publication.


ERS Publications Team

 

Prof. W.J. Fokkens – Editor in Chief

Prof. Dr. P. Hellings – Associate Editor

Dr. W.T.V. Germeraad – Managing Editor and Editorial Production Manager

editorialmanager@rhinology.org

Mrs. P. Chester – Managing Editor and Editorial Production Manager

editorialmanager@rhinologyonline.org

 

Editorial Policies

The ERS promotes transparency in all our publishing policies and processes and upholds the highest ethical standards in medical research in our field.

ERS publications follow the ICMJE’s recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals, please refer to http://www.icmje.org/urm_main.html for more information.

Please also see the Editorial Policy Statements of the Council of Science Editors (CSE), which cover the responsibilities and rights of editors of peer-reviewed journals.

 

Ethical oversight

The Editorial Management team have a responsibility to prevent unethical practice and protect patients. As such, the Editors will carefully consider the moral justification for each article submitted to Rhinology and Rhinology Online. They will assess factors such as potential burden and/or risks to patients; benefits to patients and society; to what extent the research conclusions deviate from accepted clinical practice.
If there are any concerns regarding these points, we may request further explanation from the authors’, and in some cases from their institution and/or research ethics committee.

When making a judgement, the Editors will consider factors such as differing local resources and standards for health care and research, whereby different ethical standards will apply. In such cases the final decision to publish will be based on a careful consideration of the context of the study, and the potential benefit to society.

All submissions to ERS journals will be handled in confidence by editors and reviewers.

 

Transparency

Funding

All sources of funding should be declared, including details of which aspects of the study received funding, i.e. research design, execution, analysis, interpretation, reporting.

Registering clinical trials

Clinical trials must be prospectively registered in a publicly accessible database, such as www.clinicaltrials.gov or www.clinicaltrialsregister.eu. Include the name of the trial register and your clinical trial registration number at the end of the article abstract.

Reporting guidelines

Please refer to the reporting guidelines from the EQUATOR Network, to enable readers of your article to properly evaluate your methods and results and come to their own conclusions.

Clinical trials should be reported according to CONSORT guidelines.

 

Authorship and contributorship

As per the ICMJE recommendations, to be listed as an author, you must have made significant contribution to the design and execution of the article, including:

  • acquisition, analysis, or interpretation of data
  • drafts and revisions during the writing process
  • final approval of the article before submission

As a listed author, you are also expected to be accountable for the accuracy and integrity of your part of the work undertaken.

 

Conflicts of interest / competing interests

Where an author’s private / other interests could be seen to have an impact on the objectivity and conclusions of their article this should be declared in the Conflict of Interest statement.

 

Ethics approval and consent to participate

Manuscripts reporting studies involving human participants, human data or human tissue must:

 

  • include a statement on ethics approval and consent (even where the need for approval was waived)
  • include the name of the ethics committee that approved the study and the committee’s reference number if appropriate

 

Studies involving animals must include a statement on ethics approval.

 

Consent for publication

If a study contains any individual person’s data in any form (including individual details, images or videos), consent for publication must be obtained from that person, or in the case of children, their parent or legal guardian. All presentations of case reports must have consent for publication.

Institutional consent forms or any other consent forms are acceptable. Consent forms should contain a signature of the patient/parent/ guardian/relative. It is not necessary to send the form on submission, but we may request to see a copy at any stage (including after publication).

Consent forms should be kept in the patient’s case files. The manuscript reporting this patient’s details should state that ‘Written informed consent for publication of their clinical details and/or clinical images was obtained from the patient/parent/guardian/relative of the patient. A copy of the consent form is available for review by the Editor of this journal.

 

Intellectual property

Permissions

It is the author’s responsibility to gain permission to reproduce any figures or tables in full or in part. Please provide evidence that permission has been granted where relevant.

Copyright

As Rhinology Online is an Open Access journal, all articles are covered by the Creative Commons Attribution License 4.0 in order to meet the terms of open access publication and ensure the widest possible dissemination.

For Rhinology, submission of a manuscript for publication in the journal implies the transfer of copyright from the author(s) to the publisher and entails the author’s irrevocable and exclusive authorization of the publisher to collect any sums or considerations for copying or reproduction payable by third parties. Authors will be asked to agree to these terms as part of the submission process.

 

Data sharing and reproducibility

The ERS strongly encourages that all datasets on which the conclusions of published papers rely should be available to readers. We encourage authors to ensure that their datasets are either deposited in publicly available repositories (where available and appropriate) or presented in the main manuscript or additional supporting files whenever possible.

Data citations should include a persistent identifier (such as a DOI) and should ideally be included in the reference list. Citations of datasets, when they appear in the reference list, should include the minimum information recommended by DataCite and follow journal style. Dataset identifiers including DOIs should be expressed as full URLs.

 

Post-publication discussions and corrections

In cases where editors or reviewers raise concerns about the ethical integrity of an article we reserve the right to take one of the following courses of action, as deemed appropriate:

  • Publication of a correction.
  • Retraction of published article.
  • Refusal of future submission.
  • Notification of misconduct sent to an author’s institution and/or ethics committee.

Any changes to the list of authors should be submitted to the editorial office for consideration along with a valid explanation for the change. All authors should be in agreement about any such update. Pre-publication the editors will approve any such changes on a case-by-case basis. Post-publication changes to the list of authors will typically need to be made with a published correction and will again be considered on a case-by-case basis by the editorial board.

 

Plagiarism

The Office of Research Integrity (https://ori.hhs.gov/) defines plagiarism as the “theft or misappropriation of intellectual property and the substantial unattributed textual copying of another’s work”.

Authors must therefore ensure any paraphrasing and summarising of the work of others is properly attributed and cited.

Self-plagiarism refers to reusing one’s own prior work without acknowledgement. This includes recycling text that has been previously published; submitting the same article to different publications; or reporting results of one study in separate publications when one would suffice. Once again, please therefore ensure that any summarising or paraphrasing of the author’s own work is cited appropriately.

All papers submitted to ERS journals will be screened for plagiarism by iThenticate’s advanced plagiarism detection software.

In line with guidelines from COPE (https://publicationethics.org/), if plagiarism is identified or suspected, we will contact the corresponding author with our findings. In clear cases of plagiarism of large sections of text, the submission will be rejected, and all authors will be informed of this decision. If the case is deemed serious enough, we may also refer this to the author’s institution. If the plagiarism is deemed minor (i.e. no misattribution of data) we will work with the author to ensure appropriate attribution and citation and the paper will continue through the review process.

If plagiarism is detected in an article which has already been published, the article will be retracted, and a retraction statement will be added to the website.

 

Disclaimers

While papers are subject to peer review and editing, statements and opinions expressed in articles and communications herein are those of the author(s) and not necessary those of the Editor(s), publisher or the European Rhinologic Society or the International Rhinologic Society. The Editor(s) and publisher disclaim any responsibility of liability for such material and do not guarantee, warrant, or endorse any product or service in this publication, nor do they guarantee any claim made by the manufacturer of such product or service.

 

Complaints and appeals

Any complaints about the handling of your article or appeals against an editorial decision should be addressed to editorialmanager@rhinology.org (Rhinology) or editorialmanager@rhinologyonline.org (Rhinology Online) in the first instance.

Peer-review policies

Peer-review is the system used to assess the quality of a manuscript before it is published. Independent researchers in the relevant research area assess submitted manuscripts for originality, validity and significance to help editors determine whether the manuscript should be published in their journal.
All ERS journals operate a single-blind peer-review system, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous. The benefit of single-blind peer review is that it is the traditional model of peer review that many reviewers are comfortable with, and it facilitates a dispassionate critique of a manuscript.

The journal Editor-in-Chief or nominated Handling Editor will invite appropriate reviewers, who will be asked to evaluate whether the manuscript is scientifically sound and coherent, whether it duplicates already published work, and whether the manuscript is sufficiently clear for publication. The Editors will reach a decision based on these reports and, where necessary, they will consult with members of the Editorial Board.

 

Advertising policy

There is no paid advertising in Rhinology Online. Rhinology accepts some paid advertising for relevant products and educational events. For advertising queries please contact Rhinologysecretary@amc.nl.